Category : NHS


NICE to Review Ban on Alzheimer's Drugs After Appeal

The National Institute for Health and Care Excellence has been ordered to reconsider its ban on two Alzheimer's drugs, donanemab and lecanemab, following successful appeals by manufacturers. This offers new hope for NHS access to treatments that delay dis

Page 108 of 363
Pickt mobile sticky banner — logo, tagline and CTA button